Why is Iovance Biotherapeutics stock sliding today?

More in Finance

• Avadhut Sathe case: Why ASTA may challenge SEBI order before SAT over ‘grey areas’ in stock-market education rules

  India's market regulator has cracked down heavily on unauthorized advisory operations disguised as training programs, levying massive monetary and market restrictions. In response, the targeted academy plans to contest the ruling by arguing that existing regulatory frameworks lack precise boundaries to distinguish genuine financial education from unregistered advice.

  2 min read
• US Fed Chair Kevin Warsh to bring major change to FOMC’s 2027 meeting schedule? What does it mean for rate decisions?

  Central bank officials are restructuring their routine deliberations to carve out dedicated time for overarching monetary policy strategy. This operational shift comes as policymakers balance immediate rate decisions against long-term economic planning while pursuing a 2% inflation target. Consequently, financial markets will face fewer meetings tied directly to interest rate outcomes in the coming years.

  3 min read
• Sources: Microsoft is seeking to raise $25B+ in its first US investment-grade bond sale since 2017, when it raised $17B, to fund AI-related capital expenditures (Bloomberg)

  The technology giant is tapping debt markets to secure massive financial resources dedicated specifically to artificial intelligence capital investments. This transaction marks an end to a multi-year absence from the domestic corporate debt space. The substantial scale highlights how aggressively the enterprise is backing its next-generation computing infrastructure.

  1 min read